113 related articles for article (PubMed ID: 37923100)
1. E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer.
Zhao H; Bi F; Li M; Diao Y; Zhang C
Cell Signal; 2024 Jan; 113():110961. PubMed ID: 37923100
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1.
Zhang N; Gao X; Yuan Q; Fu X; Wang P; Cai F; Liu H; Zhang J; Liang H; Nie Y; Deng J
Clin Epigenetics; 2023 May; 15(1):77. PubMed ID: 37147733
[TBL] [Abstract][Full Text] [Related]
3. RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells.
Wu Z; Liu H; Sun W; Du Y; He W; Guo S; Chen L; Zhao Z; Wang P; Liang H; Deng J
Cell Death Dis; 2020 Oct; 11(10):881. PubMed ID: 33082325
[TBL] [Abstract][Full Text] [Related]
4. RING finger gene 180 inhibits osteosarcoma progression through regulating chromobox homolog 4 ubiquitination.
Zhao Q; Liu N; Xu T; Song K
Cell Cycle; 2023 May; 22(10):1246-1258. PubMed ID: 37095741
[TBL] [Abstract][Full Text] [Related]
5. Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
Deng J; Liang H; Zhang R; Hou Y; Liu Y; Ying G; Pan Y; Hao X
Br J Surg; 2016 Mar; 103(4):407-16. PubMed ID: 26805552
[TBL] [Abstract][Full Text] [Related]
6. Knocking down of Polo-like kinase 2 inhibits cell proliferation and induced cell apoptosis in human glioma cells.
Cao F; Xia X; Fan Y; Liu Q; Song J; Zhang Q; Guo Y; Yao S
Life Sci; 2021 Apr; 270():119084. PubMed ID: 33482186
[TBL] [Abstract][Full Text] [Related]
7. Ring finger protein 180 suppresses cell proliferation and energy metabolism of non-small cell lung cancer through downregulating C-myc.
Ding Y; Lu Y; Xie X; Cao L; Zheng S
World J Surg Oncol; 2022 May; 20(1):162. PubMed ID: 35598017
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51.
Liu P; Zhou W; Yang L; Zhang C
Chem Biol Interact; 2022 Feb; 354():109798. PubMed ID: 34998818
[TBL] [Abstract][Full Text] [Related]
9. Control of SOX2 protein stability and tumorigenic activity by E3 ligase CHIP in esophageal cancer cells.
Kang L; Zhang H; Wang Y; Chu M; He J; Xue M; Pan L; Zhang Y; Wang Z; Chen Z; Huang Y; Chen Z; Li E; Li J; Xu L; Zhang R; Wong J
Oncogene; 2023 Jul; 42(30):2315-2328. PubMed ID: 37353616
[TBL] [Abstract][Full Text] [Related]
10. Importin-4 functions as a driving force in human primary gastric cancer.
Xu X; Zhang X; Xing H; Liu Z; Jia J; Jin C; Zhang Y
J Cell Biochem; 2019 Aug; 120(8):12638-12646. PubMed ID: 30861176
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer.
Cheung KF; Lam CN; Wu K; Ng EK; Chong WW; Cheng AS; To KF; Fan D; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):947-59. PubMed ID: 21717426
[TBL] [Abstract][Full Text] [Related]
12. FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development.
Ji J; Shen J; Xu Y; Xie M; Qian Q; Qiu T; Shi W; Ren D; Ma J; Liu W; Liu B
Cell Death Dis; 2022 May; 13(5):442. PubMed ID: 35525855
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer.
Xie XM; Deng JY; Hou YC; Cui JL; Wu WP; Ying GG; Dong QP; Hao XS; Liang H
Cancer Biomark; 2015; 15(3):259-65. PubMed ID: 25769451
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4
Zhang C; Leng F; Saxena L; Hoang N; Yu J; Alejo S; Lee L; Qi D; Lu F; Sun H; Zhang H
J Biol Chem; 2019 Jan; 294(2):476-489. PubMed ID: 30442713
[TBL] [Abstract][Full Text] [Related]
15. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.
Mahlokozera T; Patel B; Chen H; Desouza P; Qu X; Mao DD; Hafez D; Yang W; Taiwo R; Paturu M; Salehi A; Gujar AD; Dunn GP; Mosammaparast N; Petti AA; Yano H; Kim AH
Nat Commun; 2021 Nov; 12(1):6321. PubMed ID: 34732716
[TBL] [Abstract][Full Text] [Related]
16. AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.
Wang Z; Kang L; Zhang H; Huang Y; Fang L; Li M; Brown PJ; Arrowsmith CH; Li J; Wong J
Oncogene; 2019 Jun; 38(26):5250-5264. PubMed ID: 30894683
[TBL] [Abstract][Full Text] [Related]
17. PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1/WDR5 complexes.
Wang Q; Yu M; Ma Y; Zhang X; Zhang H; Li S; Lan R; Lu F
Lab Invest; 2018 Dec; 98(12):1627-1641. PubMed ID: 30089852
[TBL] [Abstract][Full Text] [Related]
18. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
19. RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway.
Li Y; Wang J; Wang F; Chen W; Gao C; Wang J
Cell Biol Toxicol; 2022 Oct; 38(5):809-824. PubMed ID: 33978933
[TBL] [Abstract][Full Text] [Related]
20. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
